Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB2 | P05107 | 20/20 | 0.62 |
| ▸ | ICAM1 | P05362 | 20/20 | 0.62 |
| ▸ | ITGAL | P20701 | 20/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13813631 | 0.94 | ITGB2 (0.71) | ITGB2ICAM1ITGAL | |
| SCHEMBL17991447 | 0.88 | ITGB2 (0.62) | ITGB2ICAM1ITGAL | |
| SCHEMBL23153587 | 0.87 | ITGB2 (0.65) | ITGB2ICAM1ITGAL | |
| SCHEMBL22296794 | 0.86 | ITGB2 (0.52) | ITGB2ICAM1ITGAL | |
| SCHEMBL4756023 | 0.84 | ITGB2 (0.64) | ITGB2ICAM1ITGAL | |
| SCHEMBL19158144 | 0.84 | ITGB2 (0.64) | ITGB2ICAM1ITGAL | |
| SCHEMBL18867783 | 0.80 | ITGB2 (0.47) | ITGB2ICAM1ITGAL | |
| SCHEMBL13658127 | 0.77 | ITGB2 (1.00) | ITGB2ICAM1ITGAL | |
| SCHEMBL22296796 | 0.76 | ITGB2 (0.77) | ITGB2ICAM1ITGAL | |
| SCHEMBL879397 | 0.76 | ITGB2 (0.78) | ITGB2ICAM1ITGAL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3797775-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF DIABETIC RETINOPATHY | Novartis AG (CH) | 2021-03-31 | — | — | EP | disclosed |
| EP-3167886-B1 | COMPOSITIONS AND METHODS FOR TREATMENT OF MACULAR EDEMA | NOVARTIS AG (CH) | 2020-08-05 | — | — | EP | disclosed |
| EP-3167886-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF MACULAR EDEMA | SARcode Bioscience Inc. (US) | 2017-05-17 | — | — | EP | disclosed |
| WO-2009054914-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF DIABETIC RETINOPATHY | SARCODE CORPORATION (US) | 2009-04-30 | — | — | WO | disclosed |